Invention Grant
- Patent Title: Mycoplasma arthritidis superantigen
- Patent Title (中): 支原体支原体超抗原
-
Application No.: US621081Application Date: 1996-03-22
-
Publication No.: US5795974APublication Date: 1998-08-18
- Inventor: Barry C. Cole , Curtis L. Atkin , Kevin L. Knudtson
- Applicant: Barry C. Cole , Curtis L. Atkin , Kevin L. Knudtson
- Applicant Address: UT Salt Lake City
- Assignee: University of Utah Research Foundation
- Current Assignee: University of Utah Research Foundation
- Current Assignee Address: UT Salt Lake City
- Main IPC: A61K38/00
- IPC: A61K38/00 ; C07H21/04 ; C07K14/30
Abstract:
The gene encoding the superantigen Mycoplasma arthritidis T-cell mitogen (MAM) was molecularly cloned. The mam gene was modified by site-directed mutagenesis to change UGA codons, which in mycoplasmas are read as tryptophan codons instead of universal stop codons, to UGG codons such that the gene could be expressed in standard expression systems. Recombinant MAM, including extra amino acid residues at the N- and C-termini, were expressed and discovered to be biologically active. Certain amino acid substitutions in active regions of the protein also yield biologically active MAM proteins. A method of diagnosing rheumatoid arthritis using recombinant MAM protein in an ELISA assay is disclosed.
Public/Granted literature
- US5030225A Electrically-charged nerve guidance channels Public/Granted day:1991-07-09
Information query
IPC分类: